ARWR: Arrowhead Pharmaceuticals Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Arrowhead Pharmaceuticals Inc (ARWR).
$2.41B Market Cap.
ARWR Market Cap. (MRY)
ARWR Shares Outstanding (MRY)
ARWR Assets (MRY)
Total Assets
$1.14B
Total Liabilities
$948.74M
Total Investments
$578.28M
ARWR Income (MRY)
Revenue
$3.55M
Net Income
-$599.49M
Operating Expense
$604.63M
ARWR Cash Flow (MRY)
CF Operations
-$462.85M
CF Investing
-$420.07M
CF Financing
$870.52M
ARWR Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $1,139,802,000 (48.89%) | $765,552,000 (10.64%) | $691,939,000 (-2.56%) | $710,148,000 (35.91%) |
Assets Current | $695,471,000 (65.78%) | $419,521,000 (3.51%) | $405,299,000 (5.38%) | $384,597,000 (19.30%) |
Assets Non-Current | $444,331,000 (28.41%) | $346,031,000 (20.72%) | $286,640,000 (-11.95%) | $325,551,000 (62.67%) |
Goodwill & Intangible Assets | $8,562,000 (-16.57%) | $10,262,000 (-14.21%) | $11,962,000 (-12.45%) | $13,663,000 (-11.07%) |
Shareholders Equity | $185,444,000 (-31.66%) | $271,343,000 (-31.91%) | $398,520,000 (-2.52%) | $408,822,000 (-11.47%) |
Property Plant & Equipment Net | $431,287,000 (28.53%) | $335,559,000 (99.04%) | $168,588,000 (155.36%) | $66,021,000 (40.42%) |
Cash & Equivalents | $102,685,000 (-7.40%) | $110,891,000 (2.67%) | $108,005,000 (-41.44%) | $184,434,000 (28.45%) |
Accumulated Other Comprehensive Income | $4,750,000 (247.42%) | -$3,222,000 (-2269.12%) | -$136,000 (-97.10%) | -$69,000 (-483.33%) |
Deferred Revenue | $0 (0%) | $866,000 (-99.33%) | $130,049,000 (-46.38%) | $242,550,000 (1157.32%) |
Total Investments | $578,276,000 (97.54%) | $292,735,000 (-21.78%) | $374,263,000 (-12.75%) | $428,950,000 (38.64%) |
Investments Current | $578,276,000 (97.54%) | $292,735,000 (9.07%) | $268,391,000 (46.38%) | $183,355,000 (6.66%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $105,872,000 (-56.89%) | $245,595,000 (78.63%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $1,410,000 (-86.25%) | $10,255,000 (1112.17%) |
Trade & Non-Trade Payables | $11,388,000 (-68.25%) | $35,866,000 (1150.56%) | $2,868,000 (-69.67%) | $9,457,000 (38.48%) |
Accumulated Retained Earnings (Deficit) | -$1,625,523,000 (-58.43%) | -$1,026,030,000 (-25.01%) | -$820,755,000 (-27.31%) | -$644,692,000 (-27.95%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $510,552,000 (343.30%) | $115,171,000 (41.18%) | $81,576,000 (219.34%) | $25,545,000 (20.85%) |
Debt Current | $6,342,000 (-39.96%) | $10,563,000 (280.51%) | $2,776,000 (23.38%) | $2,250,000 (105.48%) |
Debt Non-Current | $504,210,000 (382.00%) | $104,608,000 (32.75%) | $78,800,000 (238.27%) | $23,295,000 (16.23%) |
Total Liabilities | $948,739,000 (98.32%) | $478,390,000 (74.85%) | $273,600,000 (-9.20%) | $301,326,000 (396.21%) |
Liabilities Current | $103,168,000 (-2.17%) | $105,456,000 (-24.05%) | $138,850,000 (-5.25%) | $146,536,000 (260.20%) |
Liabilities Non-Current | $845,571,000 (126.73%) | $372,934,000 (176.76%) | $134,750,000 (-12.95%) | $154,790,000 (672.29%) |
ARWR Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $3,551,000 (-98.52%) | $240,735,000 (-1.03%) | $243,231,000 (75.89%) | $138,287,000 (57.16%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $98,761,000 (6.71%) | $92,549,000 (-25.62%) | $124,431,000 (53.65%) | $80,981,000 (54.91%) |
Research & Development Expense | $505,870,000 (43.23%) | $353,188,000 (18.80%) | $297,307,000 (44.08%) | $206,342,000 (60.11%) |
Operating Expenses | $604,631,000 (35.65%) | $445,737,000 (5.69%) | $421,738,000 (46.78%) | $287,323,000 (58.61%) |
Interest Expense | $32,352,000 (76.54%) | $18,326,000 (0%) | $0 (0%) | -$6,120,000 (33.41%) |
Income Tax Expense | -$2,767,000 (-199.39%) | $2,784,000 (-26.45%) | $3,785,000 (189150.00%) | $2,000 (0.00%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$609,693,000 (-191.34%) | -$209,275,000 (-18.57%) | -$176,494,000 (-25.31%) | -$140,848,000 (-66.58%) |
Net Income to Non-Controlling Interests | -$10,200,000 (-155.00%) | -$4,000,000 (-828.07%) | -$431,000 (0%) | $0 (0%) |
Net Income | -$599,493,000 (-192.04%) | -$205,275,000 (-16.59%) | -$176,063,000 (-25.00%) | -$140,848,000 (-66.58%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$599,493,000 (-192.04%) | -$205,275,000 (-16.59%) | -$176,063,000 (-25.00%) | -$140,848,000 (-66.58%) |
Weighted Average Shares | $119,784,000 (12.21%) | $106,750,000 (1.26%) | $105,426,000 (1.62%) | $103,745,000 (3.00%) |
Weighted Average Shares Diluted | $119,784,000 (12.21%) | $106,750,000 (1.26%) | $105,426,000 (1.62%) | $103,745,000 (3.00%) |
Earning Before Interest & Taxes (EBIT) | -$569,908,000 (-209.46%) | -$184,165,000 (-6.90%) | -$172,278,000 (-17.22%) | -$146,966,000 (-56.78%) |
Gross Profit | $3,551,000 (-98.52%) | $240,735,000 (-1.03%) | $243,231,000 (75.89%) | $138,287,000 (57.16%) |
Operating Income | -$601,080,000 (-193.21%) | -$205,002,000 (-14.84%) | -$178,507,000 (-19.77%) | -$149,036,000 (-59.98%) |
ARWR Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$420,072,000 (-336.87%) | -$96,155,000 (-1675.06%) | -$5,417,000 (96.18%) | -$141,678,000 (41.16%) |
Net Cash Flow from Financing | $870,520,000 (244.01%) | $253,053,000 (288.20%) | $65,186,000 (476.61%) | $11,305,000 (-95.62%) |
Net Cash Flow from Operations | -$462,851,000 (-200.77%) | -$153,890,000 (-13.05%) | -$136,131,000 (-179.46%) | $171,312,000 (278.82%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$12,403,000 (-512.33%) | $3,008,000 (103.94%) | -$76,362,000 (-286.53%) | $40,939,000 (152.06%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$278,603,000 (-445.74%) | $80,582,000 (70.15%) | $47,360,000 (140.10%) | -$118,111,000 (48.38%) |
Capital Expenditure | -$141,469,000 (19.96%) | -$176,737,000 (-234.88%) | -$52,777,000 (-123.94%) | -$23,567,000 (-97.18%) |
Issuance (Repayment) of Debt Securities | $438,866,000 (75.55%) | $250,000,000 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $431,654,000 (14038.68%) | $3,053,000 (-41.13%) | $5,186,000 (-54.13%) | $11,305,000 (-95.62%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $4,197,000 (3540.16%) | -$122,000 (-82.09%) | -$67,000 (23.86%) | -$88,000 (-121.46%) |
Share Based Compensation | $73,968,000 (-5.33%) | $78,130,000 (-35.37%) | $120,893,000 (57.67%) | $76,673,000 (76.74%) |
Depreciation Amortization & Accretion | $18,595,000 (48.84%) | $12,493,000 (19.88%) | $10,421,000 (26.06%) | $8,267,000 (39.13%) |
ARWR Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) |
Profit Margin | -16882.40% (-19691.79%) | -85.30% (-17.82%) | -72.40% (28.95%) | -101.90% (-6.04%) |
EBITDA Margin | -15525.60% (-21675.04%) | -71.30% (-7.22%) | -66.50% (33.70%) | -100.30% (-0.50%) |
Return on Average Equity (ROAE) | -206.70% (-267.79%) | -56.20% (-33.81%) | -42.00% (-30.03%) | -32.30% (-85.63%) |
Return on Average Assets (ROAA) | -66.50% (-170.33%) | -24.60% (2.77%) | -25.30% (-21.05%) | -20.90% (-37.50%) |
Return on Sales (ROS) | -16049.20% (-20879.35%) | -76.50% (-8.05%) | -70.80% (33.40%) | -106.30% (0.19%) |
Return on Invested Capital (ROIC) | -60.80% (-125.19%) | -27.00% (22.41%) | -34.80% (30.12%) | -49.80% (-25.44%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -3.87 (72.32%) | -13.99 (29.28%) | -19.79 (56.89%) | -45.9 (10.45%) |
Price to Sales Ratio (P/S) | 653.4 (5383.83%) | 11.91 (-16.82%) | 14.32 (-69.41%) | 46.84 (-4.98%) |
Price to Book Ratio (P/B) | 12.98 (22.33%) | 10.62 (20.93%) | 8.78 (-44.87%) | 15.92 (66.90%) |
Debt to Equity Ratio (D/E) | 5.12 (190.19%) | 1.76 (156.62%) | 0.69 (-6.78%) | 0.74 (458.33%) |
Earnings Per Share (EPS) | -5 (-160.42%) | -1.92 (-14.97%) | -1.67 (-22.79%) | -1.36 (-61.90%) |
Sales Per Share (SPS) | 0.03 (-98.67%) | 2.25 (-2.25%) | 2.31 (73.07%) | 1.33 (52.52%) |
Free Cash Flow Per Share (FCFPS) | -5.04 (-62.90%) | -3.1 (-72.82%) | -1.79 (-225.84%) | 1.42 (233.08%) |
Book Value Per Share (BVPS) | 1.55 (-39.10%) | 2.54 (-32.75%) | 3.78 (-4.09%) | 3.94 (-14.05%) |
Tangible Assets Book Value Per Share (TABVPS) | 9.44 (33.48%) | 7.08 (9.69%) | 6.45 (-3.92%) | 6.71 (33.33%) |
Enterprise Value Over EBIT (EV/EBIT) | -4 (75.00%) | -16 (20.00%) | -20 (52.38%) | -42 (6.67%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -4.46 (73.23%) | -16.65 (21.68%) | -21.25 (52.51%) | -44.75 (6.60%) |
Asset Turnover | 0 (-98.61%) | 0.29 (-17.48%) | 0.35 (70.24%) | 0.2 (29.75%) |
Current Ratio | 6.74 (69.46%) | 3.98 (36.28%) | 2.92 (11.20%) | 2.63 (-66.87%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$604,320,000 (-82.78%) | -$330,627,000 (-75.02%) | -$188,908,000 (-227.86%) | $147,745,000 (237.11%) |
Enterprise Value (EV) | $2,456,680,857 (-14.03%) | $2,857,673,250 (-16.93%) | $3,439,983,227 (-44.58%) | $6,207,068,352 (47.55%) |
Earnings Before Tax (EBT) | -$602,260,000 (-197.43%) | -$202,491,000 (-17.54%) | -$172,278,000 (-22.32%) | -$140,846,000 (-66.58%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$551,313,000 (-221.14%) | -$171,672,000 (-6.06%) | -$161,857,000 (-16.70%) | -$138,699,000 (-57.97%) |
Invested Capital | $1,435,939,000 (119.52%) | $654,114,000 (27.09%) | $514,698,000 (31.62%) | $391,060,000 (13.68%) |
Working Capital | $592,303,000 (88.59%) | $314,065,000 (17.87%) | $266,449,000 (11.92%) | $238,061,000 (-15.49%) |
Tangible Asset Value | $1,131,240,000 (49.78%) | $755,290,000 (11.08%) | $679,977,000 (-2.37%) | $696,485,000 (37.34%) |
Market Capitalization | $2,407,986,857 (-16.40%) | $2,880,273,250 (-17.67%) | $3,498,308,227 (-46.25%) | $6,508,905,352 (47.77%) |
Average Equity | $290,048,000 (-20.53%) | $364,996,000 (-12.95%) | $419,318,250 (-3.92%) | $436,433,250 (-10.43%) |
Average Assets | $901,249,250 (7.80%) | $836,051,250 (20.04%) | $696,458,750 (3.14%) | $675,280,250 (21.29%) |
Invested Capital Average | $936,889,000 (37.52%) | $681,287,750 (37.59%) | $495,164,500 (67.67%) | $295,327,750 (25.13%) |
Shares | 124,315,274 (15.97%) | 107,192,901 (1.27%) | 105,848,963 (1.52%) | 104,259,256 (1.92%) |
